BRIGHTGENE
BrightGene Bio-medical technology Co.,Ltd., is a leading Chinese biopharmaceutical company in small molecules and nucleotide drugs areas. Advised by China-based venture capital fund Laurel Venture Capital, BrightGene invests in all stage therapeutics and innovations.
BRIGHTGENE
Industry:
Biopharma Biotechnology
Founded:
2001-01-01
Status:
Active
Total Funding:
550 M CNY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Content Delivery Network Domain Not Resolving Mobile Non Scaleable Content DigiCert SSL GeoTrust SSL Baidu Analytics
Similar Organizations
Brickcells Technologies
Brickcells Technologies is a Biopharma company.
Enterin
Philadelphia-based biotechnology company .
Etern
Etern is a biopharma company.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Highlight Capital
Highlight Capital investment in Venture Round - BrightGene
State Development & Investment Corporation
State Development & Investment Corporation investment in Venture Round - BrightGene
GF Qianhe Investment
GF Qianhe Investment investment in Venture Round - BrightGene
Sequoia Capital China
Sequoia Capital China investment in Venture Round - BrightGene
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-07-02 | Citryll | BrightGene investment in Series B - Citryll | 18.5 M EUR |
| 2019-07-03 | Citryll | BrightGene investment in Series A - Citryll | N/A |
| 2018-08-08 | DNALite Therapeutics | BrightGene investment in Seed Round - DNALite Therapeutics | 1.5 M USD |